NasdaqCM - Nasdaq Real Time Price USD

Cyclerion Therapeutics, Inc. (CYCN)

3.2784
+0.1484
+(4.74%)
At close: May 9 at 4:00:00 PM EDT
3.5180
+0.24
+(7.31%)
After hours: May 9 at 7:27:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,000
2,000
0
297
3,320
Operating Expense
5,628
5,628
9,647
18,837
57,634
Operating Income
-3,628
-3,628
-9,647
-18,540
-54,314
Net Non Operating Interest Income Expense
208
208
358
294
-16
Other Income Expense
363
363
-3,304
--
2,683
Pretax Income
-3,057
-3,057
-12,593
-18,246
-51,647
Net Income Common Stockholders
-3,057
-3,057
-5,263
-44,078
-51,647
Diluted NI Available to Com Stockholders
-3,057
-3,057
-5,263
-44,078
-51,647
Basic EPS
-1.21
--
-2.25
-20.28
-26.40
Diluted EPS
-1.21
--
-2.25
-20.28
-26.40
Basic Average Shares
2,518
--
2,338
2,173
1,957.2000
Diluted Average Shares
2,518
--
2,338
2,173
1,957.2000
Total Operating Income as Reported
-3,628
-3,628
-12,951
-18,540
-55,195
Total Expenses
5,628
5,628
9,647
18,837
57,634
Net Income from Continuing & Discontinued Operation
-3,057
-3,057
-5,263
-44,078
-51,647
Normalized Income
-3,057
-3,057
-9,289
-18,246
-54,330
Interest Income
208
208
358
294
--
Interest Expense
--
--
--
--
16
Net Interest Income
208
208
358
294
-16
EBIT
-3,628
-3,628
-9,647
-18,540
-54,314
EBITDA
-3,628
-3,628
-9,647
-18,475
-53,842
Reconciled Depreciation
--
--
0
65
472
Net Income from Continuing Operation Net Minority Interest
-3,057
-3,057
-12,593
-18,246
-51,647
Total Unusual Items Excluding Goodwill
0
0
-3,304
0
2,683
Total Unusual Items
0
0
-3,304
0
2,683
Normalized EBITDA
-3,628
-3,628
-6,343
-18,475
-56,525
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PPBT Purple Biotech Ltd
2.2050
-0.68%
 
PEPG PepGen Inc.
1.5000
-2.60%
 
BDRX Biodexa Pharmaceuticals Plc
1.4100
+0.71%
 
TRVI Trevi Therapeutics, Inc.
6.60
0.00%
 
TTNP Titan Pharmaceuticals, Inc.
5.09
-3.60%
 
OSRH OSR Holdings, Inc.
1.2500
-2.34%
 
SLXN Silexion Therapeutics Corp
0.9848
-0.53%
 
ZLDPF Zealand Pharma A/S
64.38
0.00%
 
REVB Revelation Biosciences, Inc.
3.1781
+2.85%
 
BCDA BioCardia, Inc.
2.8500
0.00%